The global Amiodarone Hydrochloride API Market is experiencing steady growth as the prevalence of cardiovascular disorders continues to rise worldwide. Amiodarone Hydrochloride is a widely used antiarrhythmic active pharmaceutical ingredient (API) that plays a critical role in the treatment of various cardiac rhythm disorders, including ventricular arrhythmias and atrial fibrillation....

Hypertension, commonly known as high blood pressure, remains one of the most widespread chronic medical conditions globally, affecting over a billion people and standing as a major risk factor for cardiovascular disease, stroke, and kidney failure. Managing blood pressure requires long-term therapeutic interventions, lifestyle modifications, and reliable pharmaceutical formulations. Among the...

The global Capsule Filling Machines Market is poised for sustained growth as pharmaceutical and nutraceutical manufacturers continue investing in automation, precision dosing, and regulatory-compliant production systems. According to industry projections, the market is expected to expand from USD 1.9 billion in 2026 to USD 3.4 billion by 2036, registering a CAGR of 6.1% during the...

The global healthcare industry is experiencing rapid transformation as the rising prevalence of type 2 diabetes, chronic kidney disease (CKD), and cardiovascular disorders drives demand for advanced glucose-lowering therapies. According to Future Market Insights (FMI), the Dapagliflozin Market is projected to surge from USD 267.96 million in 2026 to USD 4,584.38 million by 2036, registering an...

The global Doxorubicin Market is poised for steady growth as cancer prevalence continues to rise worldwide and healthcare systems increasingly adopt advanced oncology treatments. According to the latest market analysis, the global doxorubicin market was valued at USD 1.19 billion in 2025 and is projected to grow from USD 1.27 billion in 2026 to USD 2.1 billion by 2034, registering a CAGR of...

The Ezetimibe Market is poised for steady expansion as the global Healthcare industry continues to witness rising demand for lipid-lowering therapies to manage cardiovascular diseases and hypercholesterolemia. According to Future Market Insights (FMI), the market is projected to grow from USD 19.7 million in 2026 to USD 33.4 million by 2036, registering a 5.4% CAGR during the forecast period....

NEWARK, Del., July 17, 2026 — The Generic Oncology Drugs Market is expected to witness steady growth as healthcare systems worldwide increasingly prioritize affordable cancer treatment and broader patient access to life-saving therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 24.4 billion in 2026 to USD 31.5 billion by 2036, registering a 2.6%...

According to WiseGuy Reports, the Indapamide API Market was valued at USD 744.1 million in 2024 and reached USD 776.9 million in 2025. The market is projected to grow to USD 1,200.0 million by 2035, registering a CAGR of 4.4% during the forecast period. Rising hypertension prevalence, an increasing geriatric population, expansion of the generic drug industry, supportive regulatory approvals,...

The global healthcare industry continues to witness sustained demand for antihypertensive therapies as the prevalence of hypertension, chronic kidney disease, and cardiovascular disorders rises worldwide. According to Future Market Insights (FMI), the Irbesartan Market is projected to grow from USD 72.5 million in 2026 to USD 120.4 million by 2036, registering a 5.2% CAGR during the forecast...

NEWARK, Del., July 13, 2026 — The global Healthcare industry continues to witness increasing demand for effective neurological therapies, with the Lacosamide Market benefiting from the growing prevalence of epilepsy, expanding access to generic antiepileptic medicines, and rising pharmaceutical manufacturing capabilities. According to Future Market Insights (FMI), the global Lacosamide...

The global pharmaceutical industry continues to witness steady expansion as the prevalence of cardiovascular diseases and hypertension rises across both developed and emerging economies. Nitrendipine, a calcium channel blocker widely prescribed for the management of hypertension and angina, remains an important therapeutic option in cardiovascular care. The drug works by relaxing blood vessels,...

The global pharmaceutical blister vision verification market is projected to grow from USD 225.0 million in 2026 to USD 523.0 million by 2036, registering a CAGR of 8.8% during the forecast period. The market is expanding as pharmaceutical manufacturers increasingly adopt automated vision inspection systems to enhance product quality, ensure regulatory...

According to Future Market Insights (FMI), The global pharmaceutical packaging equipment market is experiencing steady growth as pharmaceutical manufacturers increasingly invest in automated, high-precision, and compliance-ready packaging systems. Rising demand for biologics, injectables, personalized medicines, and tamper-evident packaging is accelerating the adoption of advanced...

The global Pharmaceutical Packaging Machine Market, according to Future Market Insights (FMI), is poised for steady growth, driven by rising pharmaceutical production, increasing adoption of automated packaging systems, and growing regulatory emphasis on serialization and traceability. The market is projected to grow from USD 4.5 billion in 2025 to USD 7.4 billion by 2035, registering a CAGR of...

The global pharmaceutical packaging market is projected to witness substantial expansion over the next decade as biologics production, injectable therapies, and stricter drug safety regulations reshape pharmaceutical supply chains worldwide. Growing emphasis on sterility assurance, serialization compliance, anti-counterfeit protection, and patient-friendly packaging systems continues to...

The global pharmaceutical packaging market is projected to witness substantial expansion over the next decade as biologics production, injectable therapies, and stricter drug safety regulations reshape pharmaceutical supply chains worldwide. Growing emphasis on sterility assurance, serialization compliance, anti-counterfeit protection, and patient-friendly packaging systems continues to...

The Scabies Treatment Market is expected to witness steady growth as rising prevalence of contagious skin infestations, increasing awareness of early diagnosis, and expanding access to dermatological healthcare continue to drive demand worldwide. According to Future Market Insights (FMI), the market is projected to grow from USD 228.8 million in 2026 to USD 379.9 million by 2036, registering a...

The global Small-Molecule Injectable Market, according to Future Market Insights (FMI), is entering a robust growth phase, fueled by increasing hospital pharmaceutical consumption, expanding generic injectable portfolios, and growing demand for critical care medications. The market is projected to grow from USD 162.4 billion in 2026 to USD 322.5 billion by 2036, registering a CAGR of 7.1%...